Health Canada issues interim permit to address shortage of epinephrine (adrenaline)

In order to combat shortages of Epipen (epinephrine), Health Canada has issued an interim order allowing the immediate importation of the epinephrine auto-injector AUVI-Q® manufactured in the USA and approved by the Food and Drug Administration (FDA). Importantly, AUVI-Q®is not licensed for use in Canada.

Interim orders are a method of access to unlicensed medicines and can be made when immediate action is necessary to deal with a significant risk to health, safety or the environment.  Interim orders have been used in the past to address drug shortages, notably for influenza vaccines between 2009-2010 and for naloxone spray in 2016 for the emergency treatment of drug overdose.

The interim order can be viewed here.

Tagged with

Published 10. October 2018 in News Canada